Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of methadone vs buprenorphine opioid substitution therapy on cognitive function
2009-016079-32Phase 4Completed
- Sponsor
- Universitätsklinik für Psychiatrie und Psychotherapie - Spezialambulanz für Abhängigkeitserkrankungen
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methadone, buprenorphine and naloxone in opioid use disorder (OUD) (2 arms), sponsored by Universitätsklinik für Psychiatrie und Psychotherapie - Spezialambulanz für Abhängigkeitserkrankungen. Primary endpoint: Cognitive performance (primary). Started Nov 2010; status: completed.
02
Drugs
methadonebuprenorphinenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2009-016079-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016079-32.